Skip to main content
. 2020 Mar 16;7(4):ofaa096. doi: 10.1093/ofid/ofaa096

Table 2.

Comparison of Isolated Organisms Between Low-Procalcitonin (<0.5 µg/L, Group A) and High-Procalcitonin (≥0.5 µg/L, Group B) Patient Groups

Organism, No. (%) Group A (n = 125)a Group B (n = 207)a PCT Sensitivity, %
Gram(+) aerobe, any 81 (64.8) 105 (50.7) 56.5
Gram(-) aerobe, any 43 (34.4) 103 (49.8) 70.1
Staphylococcus aureus 49 (39.2) 44 (21.3) 47.3
 MRSA 20 (16.0) 17 (8.2) 45.9
 MSSA 29 (23.2) 27 (13.0) 48.2
Escherichia coli 22 (17.6) 62 (30.0) 73.8
Klebsiella species 9 (7.2) 14 (6.8) 60.9
Viridans streptococci/NVS 9 (7.2) 16 (7.7) 64.0
Streptococcus agalactiae 8 (6.4) 2 (1.0) -
Enterococcus species 4 (3.2) 8 (3.9) -
Streptococcus pyogenes 4 (3.2) 13 (6.3) -
Staphylococcus, not aureus 4 (3.2) 5 (2.4) -
Streptococcus pneumoniae 3 (2.4) 14 (6.8) -
Haemophilus influenzae 3 (2.4) 1 (0.5) -
Pseudomonas aeruginosa 2 (1.6) 10 (4.8) -
Acinetobacter species 2 (1.6) 2 (1.0) -
Anaerobe 6 (4.8) 13 (6.3) -
Other gram(-) aerobe 5 (4.0) 14 (6.8) -
Other gram(+) aerobe 0 3 (1.4) -

Abbreviations: MRSA, methicillin-resistant Staphylococcus aureus; MSSA, methicillin-susceptible Staphylococcus aureus; NVS, nutritionally variant streptococci.

aPercentages may total >100% due to polymicrobial bacteremias.